Telephone: 44114 222 0788 Fax 44 114 272 4095 Keywords: health state utility values, baseline, quality of life, EQ-5D, age-adjusted Word Count: 3925 2 ABSTRACT Decision analytic models in healthcare require baseline health related quality of life (HRQoL) data to accurately assess the benefits of interventions. The use of inappropriate baselines such as assuming the value of perfect health (EQ-5D = 1) for not having a condition may overestimate the benefits of some treatment and thus distort policy decisions informed by cost per QALY thresholds. The primary objective was to determine if data from the general population are appropriate for baseline health state utility values (HSUVs) when condition specific data are not available.
Analytic models frequently compare the benefits of treatments that have the potential to alleviate a health condition or avoid a clinical event. Conditions and events are described by health states in the models and the health related quality of life (HRQoL) or health state utility values (HSUV) associated with these are generally obtained from clinical trials or observational studies. The baseline HRQoL used to represent the HSUVs for individuals without these conditions or events is equally relevant as these data are used to assess the HRQoL gain in alleviating or avoiding the condition or event. Ideally the baseline HSUVs would be derived from people without specific condition(s) using the definitions of health states in the model. However, these data are rarely available and a baseline of full health is commonly assumed. [1] As the average person still has other health problems, this assumption overestimates the benefits of treatment [2, 3] and it has been suggested that on average, a treatment will increase HRQoL to the same level as persons without the condition. [4] The baseline HSUVs used in decision models has important consequences as these data could distort a policy decision based on a cost per QALY threshold thus undermining efficient resource allocation. [5] When condition specific baseline data are not available, one solution has been to use ageadjusted HSUVs obtained from the general population (irrespective of health condition). [1, 2] These data will include individuals with the condition of interest hence an element of double counting is inevitable. However, unless the prevalence of the health condition is high or the affect on HRQoL is substantial, intuitively one would expect the HRQoL of the average person without a particular health condition to be similar to the HRQoL of the average person of a similar age in the general population. Researchers have shown that in cardiovascular disease (CVD) the cost per QALY results are of a similar magnitude when estimated using either a baseline from the general population or a baseline from respondents with no history of CVD. [5] The primary objective of the current study is to determine if this finding generalises to other conditions and thus if data from the general population are appropriate as baseline HSUVs in decision models. Specifically, we compare the HRQoL for subgroups who have a particular prevalent health condition (irrespective of other conditions) with a) the HRQoL from similar aged subgroups who do not have the condition (irrespective of other health conditions) and b) the HRQoL from similar aged subgroups irrespective of health status (i.e. the general population). As a secondary analysis, we compare the HRQoL for subgroups who have just one particular prevalent health condition with a) the HRQoL from similar aged subgroups who do not have any condition and b) the HRQoL from similar aged subgroups irrespective of health status (i.e. the general population).
METHODS

Data:
We used HRQoL data and information on health status collected in the Health Survey for England (HSE).
[6] The HSE is an annual survey conducted on randomly selected samples of the population living in private households in England.
[HSE] The current study pools data collected during the 2003, 2004, 2005 and 2006 surveys. Information on health status was obtained from responses to the following question: " Do you have any long-standing illness, disability or infirmity? By long-standing I mean anything that has troubled you over a period of time, or that is likely to affect you over a period of time?" Details were obtained for a maximum of six types of long-standing illnesses per person and responses were coded into 39 different health conditions. Two additional codes: "unclassifiable" and "complaint no longer present" were treated as no condition in our analyses.
HRQoL information was collected using the widely used generic questionnaire, the EQ-5D. [7] The EQ-5D contains five attributes of health status including: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each attribute is measured by a question with three possible responses: no problem, some problem, or severe problem. The combination of all possible responses leads to 243 (3^5) distinct health states. A random sample of the UK general public valued a sample of these health states using time trade-off techniques. [7] The resulting algorithm, which was used to calculate HSUVs for the current study, produces a range of -0.59 to 1, whereby 1 represents perfect health, 0 represents death and negative values represent health states considered to be worse than death.
Analysis:
Generally patients in decision analytic models are defined to match the demographic characteristics of patients who would receive the intervention under evaluation in clinical practice. Consequently, a typical patient will have concurrent health conditions and for older aged cohorts, a substantial proportion of patients will have additional prevalent health conditions. However, the effectiveness and HRQoL evidence used to assess the benefits of treatments may be derived from studies using strict recruitment criteria and patients with comorbidities can be excluded from these. As the baseline needs to reflect the definitions and data used in the model, we perform a series of analyses as described below.
i)
The primary analyses test whether data from the general population can be used as the baseline HRQoL when data from cohorts with a specific health condition (irrespective of other health conditions) are used to assess the benefits of treatment. We compare mean EQ-5D scores for these subgroups with mean EQ-5D scores from a) respondents of a similar age who did not have the specific health condition and b) respondents of a similar age irrespective of health status (i.e. the general population).
ii) The secondary analyses test whether data from the general population can be used as the baseline HRQoL when data from cohorts with a single health condition are used to assess the benefits of treatment. We compare mean EQ-5D scores for these subgroups with mean EQ-5D scores from a) respondents of a similar age who do not have any health condition and b) respondents of a similar age irrespective of health status (i.e. the general population).
iii) Exploratory analyses were also performed to test a) if the decrements on HRQoL for cohorts with a specific health condition (irrespective of other health conditions) are comparable to the decrements for cohorts with the single specific health condition (and no other condition) and b) if the decrements on HRQoL are constant across age.
All analyses were performed in STATA (v 11). Using the minimal important difference for the EQ-5D (0.074) as a benchmark, [8] and assuming a SD of 0.20 in EQ-5D scores, we used subgroups of greater than 64 (256) respondents for having the power to detect a mean difference of 0.10 (0.05) with 80% power and 5% two-sided significance. The analyses were weighted using the individual level self-administered questionnaire weights. while respondents who reported one, or more than one health condition had mean EQ-5D scores of 0.821 (range: -0.594 to 1) and 0.654 (range: -0.594 to 1) respectively.
i) Primary analyses:
With the exception of respondents who had a history of "hayfever"
(n=416), all mean EQ-5D scores for respondents who reported they had a specific health condition irrespective of whether they had other health conditions too (Table 1) were lower than the mean EQ-5D scores for the subgroups who either did not have the condition or the subgroups irrespective of health status. Four of the 39 subgroups had less than 64 respondents hence were not assessed in terms of significant differences in mean scores. As the confidence intervals of the mean EQ-5D scores did not overlap for 29/35 pairs when comparing with subgroups without the condition and 27/35 pairs when comparing with subgroups irrespective of health condition, the differences were significant at the p < 0.05 level. Comparing the mean EQ-5D scores for respondents not affected by a condition with the corresponding mean scores for respondents irrespective of health condition, the confidence intervals of the paired mean scores overlapped.
INSERT TABLE 1: Mean EQ-5D scores for respondents subgrouped by health condition
These data can be used to assess the average absolute or relative effect on HRQoL compared to the average person of a similar age who does not have the named condition, or the average person of a similar age irrespective of health status. The condition "complaints of the teeth/mouth or tongue" produced the largest average decrement on HRQoL compared to the subgroup who did not have the condition (absolute = 0.345, relative = 39%) and the subgroup from the general population (absolute = 0.344, relative = 39%). The condition "a history of stroke" produced the second largest average decrement on HRQoL compared to the subgroup who did not have the condition (absolute = 0.287, relative = 35%) and the subgroup from the general population (absolute = 0.282, relative = 34%). When compared to subgroups without the health condition, and when compared to subgroups irrespective of health status, 31/39 of the differences in mean EQ-5D scores were greater than the minimal important difference (|0.074|) for the EQ-5D. [8] ii) Secondary analyses: For the subgroups who reported they had a single specific health condition, compared to subgroups of a similar age who reported no health condition, with the exception of respondents who had a history of "hayfever" (n=186), and respondents who had a history of "poor hearing/deafness" (n=146) all mean EQ-5D scores were lower for the subgroups with the condition ( Table 2 ). 10 of the 39 subgroups had less than 64 respondents hence were not assessed in terms of significant differences in mean scores. Of the remaining 29 pairs, compared to subgroups who reported no condition, as the confidence intervals of the mean EQ-5D scores did not overlap for 22 comparisons the differences were significant at the p < 0.05 level. When comparing the mean EQ-5D scores for subgroups with a single health condition with subgroups of a similar age irrespective of health status (i.e. general population), of the 29 subgroups involving more than 64 respondents, the mean scores were greater for 13 of the subgroups with a single condition. As the CIs for the mean EQ-5D scores did not overlap for 8 of the 13 pairs, these differences were statistically significant (p < 0.05). For the remaining 16/29 subgroups with mean EQ-5D scores smaller than those of similar aged subgroups irrespective of health status, the CIs of the mean EQ-5D scores did not overlap for 5/16 comparisons (p < 0.05).
INSERT TABLE 2: Mean EQ-5D scores for respondents with a single health condition
These data can be used to assess the average absolute or relative effect on HRQoL for a single condition in isolation compared to the average person of a similar age who does not have any condition, or the average person of a similar age irrespective of health status. The condition "complaints of the teeth/mouth or tongue" produced the largest average decrement on HRQoL compared to the subgroup who had no condition (absolute = 0.290, relative = 30%) and the subgroup from the general population (absolute = 0.245, relative = 27%). The condition "a history of stroke" produced the second largest average decrement on HRQoL compared to the subgroup who had no condition (absolute = 0.254, relative = 27%) and the subgroup from the general population (absolute = 0.106, relative = 13%). When compared to subgroups without a health condition, 20/39 of the differences in mean EQ-5D scores were greater than the minimal important difference (|0.074|) for the EQ-5D while just 12/39 of the differences were greater than the MID when comparing to the subgroups irrespective of health status. [8] iii) Exploratory analyses a) Comparing average decrements on HRQoL for cohorts with a specific health condition (irrespective of other health conditions) with average decrements for corresponding cohorts with just the single specific health condition. In 14 of the 39 conditions, the average decrements on HRQoL were more than halved for the subgroups with just the one health condition (versus subgroups with no condition) compared to the average decrements on HRQoL for the subgroups with the same condition irrespective of other conditions (versus subgroups without the specific condition irrespective of other conditions) . For example the average relative decrement was 2% for respondents (n=1127) with just "asthma" when compared to respondents of a similar age without any health condition versus an average relative decrement of 10% for respondents (n=2452) with "asthma" and any other health condition when compared to respondents of a similar age without asthma. These data suggest comorbidities impose an additional decrement on HRQoL and the implication of this should be considered on an individual basis when calculating decrements attributed to the alleviation of conditions or avoidance of clinical events in economic models.
b) Comparing decrements on HRQoL across age groups
Using the full dataset, HRQoL decreased by age ( Figure 1 ) in general irrespective of the number of health conditions. The rate of decrease in HRQoL by age was greatest in respondents aged over 65 years. Comparing the mean EQ-5D scores for the youngest and oldest aged cohorts subgrouped by health status, the reduction in HRQoL was greatest for respondents with at least one health condition.
INSERT FIGURE 1: Mean EQ-5D scores stratified by age and number of health conditions
Potential trends in decrements in HRQoL by age for the individual health conditions were assessed visually by plotting mean EQ-5D scores for age and health condition stratified subgroups together with the average absolute and relative decrements ( . Due to small numbers in the age stratified data, these exploratory analyses were performed for the most prevalent health conditions only and the data were compared to respondents who did not have the relevant condition. For the cohort (n=2484) with " back problems/slipped disc/spine/neck" plus any other health condition, the average relative decrement on HRQoL compared to respondents without the condition increased by age up to the age of 80 years (Figure 2a ). This trend was also visible in the cohort (n=1106) with just " back problems/slipped disc/spine/neck" (Figure 2b ) when compared to respondents with no health condition. The age stratified average absolute decrements (range 0.19 to 0.29) were similar for the cohorts with or without comorbid health conditions. Compared to the respondents without the condition, as the CIs for the mean EQ-5D scores did not cross, all the age stratified decrements were statistically significant at the 95% level.
INSERT FIGURE 2:
Mean EQ-5D scores and decrements on HRQoL for respondents with "back problems/slipped disc/spine/neck" Conversely, for the cohort (n= 3172) with "hypertension/high blood pressure/blood" plus any other condition the relative decrement on HRQoL compared to respondents without the condition decreased by age with the largest effects observed in respondents younger than 60 years ( Figure 3a ). The average effect on HRQoL was much smaller across all age groups for the cohort with just "hypertension/high blood pressure/blood" (n=974) compared to the average effect on HRQoL for the cohort with "hypertension/high blood pressure/blood" and any other health condition ( Figure 3b ).
For the cohort (n=4145) with "arthritis/rheumatism/fibrositis" plus any other health condition, the average relative decrement on HRQoL compared to subgroups without the condition decreased slightly by age for respondents aged over 40 years ( Figure 4 ).
Conversely, for the cohort (n=1358) with just "arthritis/rheumatism/fibrositis" and no other condition, compared to respondents with no health condition, the average relative decrement on HRQoL increased by age. When comparing the mean EQ-5D scores from cohorts with just "arthritis/rheumatism/fibrositis" with the mean EQ-5D scores for cohorts with "arthritis/rheumatism/fibrositis" plus any other condition the confidence intervals of the mean EQ-5D scores did not overlap for the cohorts aged between 40 years and 70 years only. All age and condition specific mean EQ-5D scores used in the analyses which are not discussed in the article are provided in the online appendix.
DISCUSSION
This study provides EQ-5D scores obtained from non institutionalised residents in England stratified by self-reported history of prevalent health condition(s) and age (where sample sizes permit There are limitations with the data used in this study. In particular the health conditions are self-reported and no information was collected that could be used to determine either the duration of the health condition or the severity of the condition. There was a great deal of individual variation for respondents reporting the same health condition and this could be partly attributable to the wide range in severity of and duration of condition included within a single subgroup. The coded conditions are not exhaustive and it is probable that some respondents had health conditions which are not included in the analyses. As the conditions that are not identified are not prevalent this is unlikely to affect our main findings. The surveys did not sample from people in nursing homes or other institutions who are likely to have lower HRQoL on average than those residing in their own home. This is more likely to have an effect on the HSUVs for the older aged cohorts and it could be that the actual average EQ-5D scores for these subgroups are lower than we report. This may have an impact on the age related trends in the decrements for the different health conditions and additional research in this area would be interesting.
Some of the mean HSUVs for subgroups with a particular condition are lower than the corresponding values for subgroups without the condition or those from respondents irrespective of health status which initially appears counter intuitive. For the analyses conducted on subgroups with just one health condition, one possible explanation for higher HSUVs for the respondents with a condition is that the average person in the general population will in fact have a lower HSUV as the combined decrements on HRQoL for the prevalent conditions could be larger than the decrement for the single condition.
Decision analytic models of health care interventions require a baseline HRQoL profile to accurately calculate the benefits of treatment. These data would ideally be derived from respondents who do not have the exact definition of the health condition(s) being modelled.
When these data are not available, the current study provides a number of age and health condition stratified HSUVs that can be used to assess the benefits of treatment compared to the average person who does not have the condition. Our results suggest age adjusted HSUV from the general population could be used as the baseline when modelling the benefits of treatment for individuals with comorbidities. However, these data are not appropriate when All CIs for mean EQ-5D overlap (p>0.05) when comparing: respondents not affected by the condition versus irrespective of health status † CIs for mean EQ-5D do not overlap (p<0.05) when comparing: respondents with the condition versus respondents not affected by the condition ‡ CIs for mean EQ-5D do not overlap (p<0.05) when comparing: respondents with the condition versus respondents irrespective of health status ~ proportion of respondents affected by the health condition who reported at least one other condition 
